|
Name |
3-Demethoxyl-fusarnaphthoquinone B
|
Molecular Formula | C14H14O4 | |
IUPAC Name* |
5,9-dihydroxy-2,4-dimethyl-8,9-dihydro-7H-benzo[g][1]benzofuran-6-one
|
|
SMILES |
Cc1cc2c(C)c(O)c3c(c2o1)C(O)CCC3=O
|
|
InChI |
InChI=1S/C14H14O4/c1-6-5-8-7(2)13(17)11-9(15)3-4-10(16)12(11)14(8)18-6/h5,10,16-17H,3-4H2,1-2H3/t10-/m1/s1
|
|
InChIKey |
HVPSURWZNWORSR-SNVBAGLBSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 246.26 | ALogp: | 2.8 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 70.7 | Aromatic Rings: | 3 |
Heavy Atoms: | 18 | QED Weighted: | 0.745 |
Caco-2 Permeability: | -4.885 | MDCK Permeability: | 0.00001260 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.865 |
Human Intestinal Absorption (HIA): | 0.077 | 20% Bioavailability (F20%): | 0.016 |
30% Bioavailability (F30%): | 0.962 |
Blood-Brain-Barrier Penetration (BBB): | 0.085 | Plasma Protein Binding (PPB): | 90.72% |
Volume Distribution (VD): | 0.874 | Fu: | 8.69% |
CYP1A2-inhibitor: | 0.753 | CYP1A2-substrate: | 0.896 |
CYP2C19-inhibitor: | 0.059 | CYP2C19-substrate: | 0.806 |
CYP2C9-inhibitor: | 0.117 | CYP2C9-substrate: | 0.716 |
CYP2D6-inhibitor: | 0.076 | CYP2D6-substrate: | 0.315 |
CYP3A4-inhibitor: | 0.051 | CYP3A4-substrate: | 0.309 |
Clearance (CL): | 7.445 | Half-life (T1/2): | 0.538 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.513 |
Drug-inuced Liver Injury (DILI): | 0.755 | AMES Toxicity: | 0.503 |
Rat Oral Acute Toxicity: | 0.563 | Maximum Recommended Daily Dose: | 0.729 |
Skin Sensitization: | 0.323 | Carcinogencity: | 0.529 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.092 |
Respiratory Toxicity: | 0.753 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002706 | 0.635 | D0FA2O | 0.333 | ||||
ENC004895 | 0.478 | D0G4KG | 0.275 | ||||
ENC003030 | 0.451 | D07MGA | 0.236 | ||||
ENC004989 | 0.444 | D0YH0N | 0.221 | ||||
ENC004786 | 0.422 | D0J4IX | 0.220 | ||||
ENC003146 | 0.418 | D09EBS | 0.220 | ||||
ENC004789 | 0.413 | D0H6QU | 0.218 | ||||
ENC005719 | 0.406 | D06XZW | 0.216 | ||||
ENC003553 | 0.397 | D0O6KE | 0.212 | ||||
ENC001952 | 0.397 | D0K7WK | 0.204 |